Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 7 studies | 37% ± 25% | |
astrocyte | 7 studies | 29% ± 13% | |
GABAergic neuron | 6 studies | 38% ± 23% | |
endothelial cell | 5 studies | 25% ± 9% | |
interneuron | 5 studies | 33% ± 20% | |
adipocyte | 5 studies | 20% ± 3% | |
oligodendrocyte precursor cell | 5 studies | 31% ± 12% | |
macrophage | 4 studies | 21% ± 5% | |
neuron | 4 studies | 24% ± 10% | |
oligodendrocyte | 4 studies | 22% ± 5% | |
microglial cell | 3 studies | 21% ± 2% | |
fibroblast | 3 studies | 18% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 8 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 894.16 | 328 / 328 | 100% | 12.85 | 178 / 178 |
prostate | 100% | 2191.52 | 245 / 245 | 100% | 23.23 | 502 / 502 |
thymus | 100% | 2375.62 | 653 / 653 | 100% | 22.03 | 605 / 605 |
brain | 100% | 2339.16 | 2640 / 2642 | 100% | 27.58 | 705 / 705 |
breast | 100% | 1469.87 | 459 / 459 | 100% | 17.26 | 1117 / 1118 |
skin | 100% | 1167.74 | 1806 / 1809 | 100% | 20.71 | 471 / 472 |
kidney | 100% | 1390.31 | 89 / 89 | 100% | 14.06 | 897 / 901 |
esophagus | 100% | 1271.56 | 1442 / 1445 | 99% | 10.85 | 182 / 183 |
uterus | 100% | 2318.86 | 170 / 170 | 99% | 17.97 | 455 / 459 |
ovary | 100% | 2185.57 | 180 / 180 | 99% | 12.94 | 425 / 430 |
bladder | 100% | 1581.76 | 21 / 21 | 99% | 13.43 | 497 / 504 |
lung | 99% | 1047.03 | 570 / 578 | 100% | 13.83 | 1150 / 1155 |
stomach | 100% | 1150.76 | 358 / 359 | 98% | 9.38 | 280 / 286 |
adrenal gland | 100% | 1626.39 | 258 / 258 | 97% | 15.27 | 224 / 230 |
intestine | 100% | 1511.22 | 966 / 966 | 97% | 8.25 | 511 / 527 |
liver | 99% | 686.91 | 224 / 226 | 98% | 10.02 | 397 / 406 |
adipose | 100% | 1483.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.98 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.96 | 29 / 29 |
spleen | 100% | 1702.50 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.84 | 1 / 1 |
muscle | 100% | 1397.36 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1172.51 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1064.08 | 837 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 828.34 | 859 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0000070 | Biological process | mitotic sister chromatid segregation |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0051301 | Biological process | cell division |
GO_0032480 | Biological process | negative regulation of type I interferon production |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0007094 | Biological process | mitotic spindle assembly checkpoint signaling |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0071233 | Biological process | cellular response to L-leucine |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005827 | Cellular component | polar microtubule |
GO_0005813 | Cellular component | centrosome |
GO_0005764 | Cellular component | lysosome |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0045171 | Cellular component | intercellular bridge |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KLHL22 |
Protein name | Kelch-like protein 22 Kelch like family member 22 |
Synonyms | |
Description | FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex required for chromosome alignment and localization of PLK1 at kinetochores. The BCR(KLHL22) ubiquitin ligase complex mediates monoubiquitination of PLK1, leading to PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation. Monoubiquitination of PLK1 does not lead to PLK1 degradation . The BCR(KLHL22) ubiquitin ligase complex is also responsible for the amino acid-stimulated 'Lys-48' polyubiquitination and proteasomal degradation of DEPDC5. Through the degradation of DEPDC5, releases the GATOR1 complex-mediated inhibition of the TORC1 pathway. It is therefore an amino acid-dependent activator within the amino acid-sensing branch of the TORC1 pathway, indirectly regulating different cellular processes including cell growth and autophagy . . |
Accessions | ENST00000328879.9 [Q53GT1-1] ENST00000458248.5 C9J5F8 C9JLE9 C9J2T1 ENST00000451553.1 ENST00000444967.5 Q53GT1 C9J191 C9JHG1 C9JRG9 ENST00000423364.1 ENST00000443285.5 ENST00000431430.1 |